Takeda Pharmaceutical Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Takeda Pharmaceutical Stock Summary

Takeda Pharmaceutical competes with Viatris, Elanco Animal, Zoetis, Emergent Biosolutions, and Prestige Brand. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 47347 people.

Takeda Pharmaceutical Key Financial Ratios

Takeda Pharmaceutical Key Balance Sheet Accounts

Takeda Pharmaceutical Key Income Statement Accounts

Takeda Pharmaceutical Key Cash Accounts

Takeda Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Takeda Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Takeda Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Takeda Pharmaceutical competition to find correlations between indicators driving Takeda Pharmaceutical's intrinsic value. More Info.Takeda Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.85  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Takeda Pharmaceutical Co is roughly  1.17 . At this time, Takeda Pharmaceutical's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Takeda Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Takeda Pharmaceutical Systematic Risk

Today, most investors in Takeda Pharmaceutical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Takeda Pharmaceutical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Takeda Pharmaceutical growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Takeda Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Takeda Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Takeda Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Takeda Pharmaceutical's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.